Science Explorer Back to mapMap
Discussion
Company · Abingdon · United Kingdom

Adaptimmune (United Kingdom)

adaptimmune.comROR OpenAlex
Research works
101
◆ 2% vs 2018-21
Citations
2.9k
28.5 per fractional work
Top-10% rate
8.4%
all institutions 10.0%
Open access
51%
world 40%
International
48%
world 18%
Adaptimmune (United Kingdom)

Not ranked overall: Adaptimmune (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Adaptimmune (United Kingdom) work in?

In 2022-now, 33% of research at Adaptimmune (United Kingdom) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (33%), Immunology and Microbiology (18%), Engineering (12%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 7 fractional works · 32.5% of its workMedicine: 7 fractional works · 32.5% of its workOncology: 5 fractional works · 20.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 5.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.9% of its workEpidemiology: 0 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workOphthalmology: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.2% of its workNeurology: 0 fractional works · 0.2% of its workSurgery: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workLife Sciences: 6 fractional works · 29.0% of its workImmunology and Microbiology: 4 fractional works · 17.7% of its workImmunology: 4 fractional works · 17.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 9.6% of its workMolecular Biology: 1 fractional works · 5.4% of its workBiotechnology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.1% of its workStructural Biology: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.7% of its workPlant Science: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 22.6% of its workEngineering: 3 fractional works · 11.6% of its workElectrical and Electronic Engineering: 2 fractional works · 8.5% of its workAerospace Engineering: 0 fractional works · 1.5% of its workAutomotive Engineering: 0 fractional works · 0.4% of its workCivil and Structural Engineering: 0 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workMechanical Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 2 fractional works · 8.4% of its workArtificial Intelligence: 1 fractional works · 5.5% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workHuman-Computer Interaction: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 1.5% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.8% of its workRadiation: 0 fractional works · 0.8% of its workEnergy: 0 fractional works · 0.8% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.8% of its workChemistry: 0 fractional works · 0.2% of its workAnalytical Chemistry: 0 fractional works · 0.2% of its workSocial Sciences: 3 fractional works · 15.9% of its workSocial Sciences: 2 fractional works · 9.0% of its workEducation: 1 fractional works · 2.7% of its workAnthropology: 0 fractional works · 2.3% of its workSociology and Political Science: 0 fractional works · 1.9% of its workPolitical Science and International Relations: 0 fractional works · 1.0% of its workPublic Administration: 0 fractional works · 0.4% of its workSafety Research: 0 fractional works · 0.4% of its workDemography: 0 fractional works · 0.3% of its workArts and Humanities: 1 fractional works · 3.2% of its workLanguage and Linguistics: 0 fractional works · 2.3% of its workVisual Arts and Performing Arts: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 2.1% of its workSocial Psychology: 0 fractional works · 1.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 1.2% of its workInformation Systems and Management: 0 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKAdaptimmune(United Kingdom)22fractional works, 2022-now
Life Sciences29%Physical Sciences23%Health Sciences33%Social Sciences16%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine732.5%
    1. Immunology and Microbiology417.7%
    2. Biochemistry, Genetics and Molecular Biology29.6%
    3. Agricultural and Biological Sciences01.7%
    1. Engineering311.6%
    2. Computer Science28.4%
    3. Physics and Astronomy01.5%
    4. Energy00.8%
    5. Chemistry00.2%
    1. Social Sciences29.0%
    2. Arts and Humanities13.2%
    3. Psychology02.1%
    4. Decision Sciences01.2%
    5. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.80× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 17.58× its world share, 4 worksImmunology and Micro…Chemistry: 0.14× its world share, 0 worksChemistryComputer Science: 1.08× its world share, 2 worksComputer ScienceEnergy: 0.84× its world share, 0 worksEnergyEngineering: 0.78× its world share, 2 worksEngineeringPhysics and Astronomy: 0.69× its world share, 0 worksPhysics and AstronomyMedicine: 1.69× its world share, 7 worksMedicineArts and Humanities: 1.12× its world share, 1 worksArts and HumanitiesDecision Sciences: 1.20× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.18× its world share, 0 worksEconomics, Econometr…Psychology: 0.69× its world share, 0 worksPsychologySocial Sciences: 0.71× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.6×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology17.58×4 works
  2. Biochemistry, Genetics and Molecular Biology1.80×2 works
  3. Medicine1.69×7 works
  4. Decision Sciences1.20×0 works
  5. Arts and Humanities1.12×1 works
  6. Computer Science1.08×2 works
  7. Energy0.84×0 works
  8. Engineering0.78×2 works
  9. Social Sciences0.71×2 works
  10. Physics and Astronomy0.69×0 works
  11. Psychology0.69×0 works
  12. Agricultural and Biological Sciences0.36×0 works
  13. Economics, Econometrics and Finance0.18×0 works
  14. Chemistry0.14×0 works

Who are the top researchers at Adaptimmune (United Kingdom)?

Ranked on the quality score, Rafael G. Amado, Gwendolyn K. Binder-Scholl and Tom Holdich lead among researchers whose main affiliation is Adaptimmune (United Kingdom).

  1. 1 Rafael G. Amado United Kingdom · #263,817 worldwide 9.5k citations · 76 works
  2. 2 Gwendolyn K. Binder-Scholl United Kingdom · #582,796 worldwide 5.3k citations · 32 works
  3. 3 Tom Holdich United Kingdom · #681,909 worldwide 2k citations · 36 works
  4. 4 Luca Melchiori United Kingdom · #695,135 worldwide 2.6k citations · 34 works
  5. 5 Elliot Norry United Kingdom · #699,555 worldwide 1.2k citations · 44 works
  6. 6 Joseph P. Sanderson United Kingdom · #765,777 worldwide 1.6k citations · 40 works
  7. 7 Andrew B. Gerry United Kingdom · #829,072 worldwide 3.8k citations · 52 works
  8. 8 Cheryl McAlpine United Kingdom · #1,140,121 worldwide 883 citations · 26 works
  9. 9 Nicholas J. Pumphrey United Kingdom · #1,197,564 worldwide 2.4k citations · 21 works
  10. 10 Daniel D. Williams United Kingdom · #1,655,636 worldwide 2.1k citations · 35 works
All ranked researchers at Adaptimmune (United Kingdom)

What are the most cited papers from Adaptimmune (United Kingdom)?

The most cited paper from Adaptimmune (United Kingdom) is "Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma" (Gerald P. Linette et al., 2013), with 1,200 citations. Next come "NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma" (863) and "Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells" (700).

Most cited papers
#PaperReleasedCitations
1 Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma Gerald P. Linette et al. · Blood Open access 14 Jun 2013 1,200
2 NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Aaron P. Rapoport et al. · Nature Medicine Open access 20 Jul 2015 863
3 Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells Brian Cameron et al. · Science Translational Medicine Open access 7 Aug 2013 700
4 Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors Jason J. Luke, Jeffrey M. Lemons, Theodore G Karrison et al. · Journal of Clinical Oncology Open access 13 Feb 2018 597
5 Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma Sandra P. D’Angelo et al. · Cancer Discovery Open access 11 Jun 2018 444
All 60 most cited papers, with filters and sorting

Which keywords describe research at Adaptimmune (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Antigen Presentation, Dendritic Cells and Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Immunotherapy6▲ 175×2 topics
  2. Immunotherapy4▲ 23×6 topics
  3. Tumor Regression4▲ 144×2 topics
  4. CAR T Cells3▲ 206×1 topic
  5. Chimeric Antigen Receptor3▲ 206×1 topic
  6. Antigen Presentation3▲ 138×2 topics
  7. Dendritic Cells2▲ 132×1 topic
  8. Immunity2▲ 29×1 topic
  9. Prognostic Factors1▲ 13×4 topics
  10. Wireless Power Transfer1▲ 69×2 topics
  11. Immune Checkpoint Blockade1▲ 48×1 topic
  12. PD-1 and PD-L11▲ 48×1 topic
  13. Tumor Microenvironment1▲ 13×3 topics
  14. Chemotherapy1▲ 7.5×3 topics
  15. Clinical Practice Guidelines1▲ 9.2×2 topics
  16. Osteosarcoma1▲ 106×1 topic
  17. Soft Tissue Sarcoma1▲ 94×1 topic

Which research topics does Adaptimmune (United Kingdom) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and Sarcoma Diagnosis and Treatment.

CAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksImmunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksSarcoma Diagnosis and Tr…1Sarcoma Diagnosis and Treatment: 1 fractional worksImmune Cell Function and…1Immune Cell Function and Interaction: 1 fractional worksWireless Power Transfer …1Wireless Power Transfer Systems: 1 fractional worksEnergy Harvesting in Wireless Networks: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksAI-based Problem Solving and Planning: 0 fractional worksMachine Learning and Data Classification: 0 fractional works
OncologyImmunologyPulmonary and Respiratory MedicineElectrical and Electronic Engineering2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  5. 5 Immune Cell Function and Interaction Immunology 1 works
  6. 6 Wireless Power Transfer Systems Electrical and Electronic Engineering 1 works
  7. 7 Energy Harvesting in Wireless Networks Electrical and Electronic Engineering 1 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  9. 9 AI-based Problem Solving and Planning Artificial Intelligence 0 works
  10. 10 Machine Learning and Data Classification Artificial Intelligence 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.6%not open49.4%

World: 40% of research is openly available.

with international co-authors48.1%domestic only51.9%

World: 18% is written across borders.

How has Adaptimmune (United Kingdom)'s research output changed?

Output in 2022-2025 was 2% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Adaptimmune (United Kingdom) as a percentage of every work published that year, 0.000083% in 2024.

still counting0.00020%0.00040%0.00060%Adaptimmune (United Kingdom)0.000084% in 202519801990200020102020

Fractional works of Adaptimmune (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Abingdon

All research institutions in Abingdon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Adaptimmune (United Kingdom). Posts are plain text and can be reported.